Clinical Application of Non-invasive Diagnosis for Hepatic Fibrosis |
Sung Won Cho , Jae Youn Cheong |
Gastroenterology Department, Ajou University School of Medicine, Suwon, Korea |
|
|
ABSTRACT |
|
Progressive hepatic fibrosis with development of cirrosis is a feature of chronic liver disease. Assessing
fibrosis is important for predicting disease progression and patient management. Liver biopsy is the current
gold standard for the diagnosis of liver fibrosis. However, liver biopsy is an invasive procedure. Alternative
non-invasive methods have been developed. Serum markers are useful in predicting liver cirrhosis, but
accuracy of serum markers is not satisfactory in the assessment of fibrosis. Newly developed transient
elastography (Fibroscan) is a non-invasive method of measuring liver stiffness. Fibroscan has been reported
to be superior in early detection of cirrhosis to serum markers. Factors influencing it’s performance are not
fully investigated. The evaluation of new tests should be continued to perform. (Korean J Hepatol
2007;13:129-137) |
KeyWords:
Hepatic fibrosis; Diagnosis; Liver cirrhosis |
|
|